aTyr Pharma, Inc.
ATYR
$4.06
$0.0651.63%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.84% | -5.26% | -4.95% | -30.16% | 8.09% |
| Total Depreciation and Amortization | 1.31% | -50.26% | 89.19% | -59.01% | 69.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,862.50% | 88.06% | 70.61% | 27.62% | -30.71% |
| Change in Net Operating Assets | 179.06% | 40.49% | -315.74% | 219.04% | 6,588.24% |
| Cash from Operations | 35.65% | 8.63% | -102.31% | -15.72% | 20.41% |
| Capital Expenditure | -87.50% | 52.94% | 0.00% | 96.95% | 76.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 166.64% | 603.06% | -107.51% | 261.03% | 378.15% |
| Cash from Investing | 166.74% | 596.17% | -107.61% | 306.53% | 205.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.63% | -1.65% | -5.22% | -6.48% | -2.86% |
| Issuance of Common Stock | -99.85% | 72.25% | 27.68% | 120.39% | -65.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.78% | 73.35% | 28.11% | 124.98% | -66.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,558.88% | 97.99% | -225.14% | 612.83% | 69.39% |
